The devolution of biosimilars regulations
Crossref DOI link: https://doi.org/10.1038/s41587-024-02497-5
Published Online: 2024-12-16
Published Print: 2025-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Doevendans, Erik
van Meer, Peter
Schellekens, Huub https://orcid.org/0000-0002-8503-3965
Text and Data Mining valid from 2024-12-16
Version of Record valid from 2024-12-16
Article History
First Online: 16 December 2024
Competing interests
: The authors declare no competing interests.